![logo](/logos/300642.SZ.webp)
Tellgen Corporation
SZSE:300642.SZ
18.68 (CNY) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Tellgen Corporation |
Symbool | 300642.SZ |
Munteenheid | CNY |
Prijs | 16.36 |
Beurswaarde | 2,686,410,160 |
Dividendpercentage | 1.44% |
52-weken bereik | 15.96 - 25.32 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Jian Er Yao |
Website | https://www.tellgen.com |
An error occurred while fetching data.
Over Tellgen Corporation
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. It offers tumor markers, human papilloma virus test kits, ToRCH products, Y chromosome microdeletions test kits, and multiplex immunoassay systems. The company was founded in 2003 and is based in Shanghai, China.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)